4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-17-039836
$TCRTCIK 0001107421operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:31 PM ET
Size
7.0 KB
Accession
0001209191-17-039836
Insider Transaction Report
Form 4
CANNON JAMES ANTHONY
Director
Transactions
- Exercise/Conversion
Common Stock
2017-06-12$4.85/sh+15,000$72,750→ 367,502 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-06-12−15,000→ 0 totalExercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]5,000 shares vested and became exercisable on each of 6/18/08, 6/18/09 and 6/18/10.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:31 PM ET
- Size
- 7.0 KB